Momenta Pharmaceuticals, Inc. (MNTA)

[funindasun]

Potential Uses of M254

IVIG Therapy is FDA approved for the treatment of:

*Primary immunodeficientcy
*Autoimmune thrombocytopenia
*The vascular disorder Kawasaki disease
*Hematopoietic stem cell or bone marrow transplantation in patients older than two years
*Chronic B-cell lymphocytic leukemia
*Prevention of craft vs. host disease in transplant patients, and
*Pediatric HIV-1 infection
*Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

IVIG Therapy is also used off-label in the treatment of:

*Aplastic anemia
*Red blood cell aplasia
*Autoimmune hemolytic anemia
*Hemolytic disease of the newborn
*Patients with acquired clotting factor inhibitors
*Acquired von Willebrand disease
*Immune-mediated neutropenia
*Blood transfusion reaction or consequences
*Multiple sclerosis
*CIDP
*Rheumatoid arthritis
*Patients with trauma, burns, low birth weight, or HIV infection